Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuangpeng Zhu

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Pharmaceutics|March 28, 2026
Cost-Efficient and Fast At-Line Assessment of Content and Uniformity in Low-Dose Dimdazenil Capsules Using Transmission Raman SpectroscopyXun Ma, Lianlian Shan, Shuangpeng Zhu, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 14, 2018
Simultaneous quantification of EVT201, a novel partial positive allosteric GABA<sub>A</sub> receptor modulator, and its two metabolites in human plasma by UHPLC/MS/MSXianhua Zhang, Congya Zhou, Yuanyuan Zhang, et al.
Sleep|October 24, 2023
Efficacy and safety of Dimdazenil in adults with insomnia disorder: results from a multicenter, randomized, double-blind, placebo-controlled phase III trialsZhaoyang Huang, Shuqin Zhan, Chunyan Chen, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Pharmaceutics|March 28, 2026
Cost-Efficient and Fast At-Line Assessment of Content and Uniformity in Low-Dose Dimdazenil Capsules Using Transmission Raman SpectroscopyXun Ma, Lianlian Shan, Shuangpeng Zhu, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 14, 2018
Simultaneous quantification of EVT201, a novel partial positive allosteric GABA<sub>A</sub> receptor modulator, and its two metabolites in human plasma by UHPLC/MS/MSXianhua Zhang, Congya Zhou, Yuanyuan Zhang, et al.
Sleep|October 24, 2023
Efficacy and safety of Dimdazenil in adults with insomnia disorder: results from a multicenter, randomized, double-blind, placebo-controlled phase III trialsZhaoyang Huang, Shuqin Zhan, Chunyan Chen, et al.
Pageof 1